Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 158


Dietary manganese modulates PCB126 toxicity, metal status and MnSOD in the rat.

Wang B, Klaren WD, Wels BR, Simmons DL, Olivier AK, Wang K, Robertson LW, Ludewig G.

Toxicol Sci. 2015 Dec 10. pii: kfv312. [Epub ahead of print]


Progression of micronutrient alteration and hepatotoxicity following acute PCB126 exposure.

Klaren WD, Gadupudi GS, Wels B, Simmons DL, Olivier AK, Robertson LW.

Toxicology. 2015 Dec 2;338:1-7. doi: 10.1016/j.tox.2015.09.004. Epub 2015 Sep 26.


Effects of TZD Use and Discontinuation on Fracture Rates in ACCORD Bone Study.

Schwartz AV, Chen H, Ambrosius WT, Sood A, Josse RG, Bonds DE, Schnall AM, Vittinghoff E, Bauer DC, Banerji MA, Cohen RM, Hamilton BP, Isakova T, Sellmeyer DE, Simmons DL, Shibli-Rahhal A, Williamson JD, Margolis KL.

J Clin Endocrinol Metab. 2015 Nov;100(11):4059-66. doi: 10.1210/jc.2015-1215. Epub 2015 Aug 25.


Uncontrolled combustion of shredded tires in a landfill - Part 1: Characterization of gaseous and particulate emissions.

Downard J, Singh A, Bullard R, Jayarathne T, Rathnayake C, Simmons DL, Wels BR, Spak SN, Peters T, Beardsley D, Stanier C, Stone EA.

Atmos Environ (1994). 2015 Mar 1;104:195-204.


Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD trial.

Margolis KL, Palermo L, Vittinghoff E, Evans GW, Atkinson HH, Hamilton BP, Josse RG, O'Connor PJ, Simmons DL, Tiktin M, Schwartz AV.

J Gen Intern Med. 2014 Dec;29(12):1599-606. doi: 10.1007/s11606-014-2961-3. Epub 2014 Aug 16.


Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial.

Punthakee Z, Miller ME, Simmons DL, Riddle MC, Ismail-Beigi F, Brillon DJ, Bergenstal RM, Savage PJ, Hramiak I, Largay JF, Sood A, Gerstein HC; ACCORD Group of Investigators.

Diabetologia. 2014 Oct;57(10):2030-7. doi: 10.1007/s00125-014-3318-5. Epub 2014 Jul 2.


Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial.

Linz PE, Lovato LC, Byington RP, O'Connor PJ, Leiter LA, Weiss D, Force RW, Crouse JR, Ismail-Beigi F, Simmons DL, Papademetriou V, Ginsberg HN, Elam MB.

Diabetes Care. 2014;37(3):686-93. doi: 10.2337/dc13-0790. Epub 2013 Dec 2.


Low- and high-cocaine locomotor responding rats differ in reinstatement of cocaine seeking and striatal mGluR5 protein expression.

Simmons DL, Mandt BH, Ng CM, Richards TL, Yamamoto DJ, Zahniser NR, Allen RM.

Neuropharmacology. 2013 Dec;75:347-55. doi: 10.1016/j.neuropharm.2013.08.001. Epub 2013 Aug 22.


Does dietary copper supplementation enhance or diminish PCB126 toxicity in the rodent liver?

Lai IK, Klaren WD, Li M, Wels B, Simmons DL, Olivier AK, Haschek WM, Wang K, Ludewig G, Robertson LW.

Chem Res Toxicol. 2013 May 20;26(5):634-44. doi: 10.1021/tx400049s. Epub 2013 Apr 15.


Targeting kinases: a new approach to treating inflammatory rheumatic diseases.

Simmons DL.

Curr Opin Pharmacol. 2013 Jun;13(3):426-34. doi: 10.1016/j.coph.2013.02.008. Epub 2013 Mar 19. Review.


Cardiovascular risk assessment: addition of CKD and race to the Framingham equation.

Drawz PE, Baraniuk S, Davis BR, Brown CD, Colon PJ Sr, Cujyet AB, Dart RA, Graumlich JF, Henriquez MA, Moloo J, Sakalayen MG, Simmons DL, Stanford C, Sweeney ME, Wong ND, Rahman M.

Am Heart J. 2012 Dec;164(6):925-31.e2. doi: 10.1016/j.ahj.2012.09.003. Epub 2012 Oct 29.


Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial.

Schwartz AV, Margolis KL, Sellmeyer DE, Vittinghoff E, Ambrosius WT, Bonds DE, Josse RG, Schnall AM, Simmons DL, Hue TF, Palermo L, Hamilton BP, Green JB, Atkinson HH, O'Connor PJ, Force RW, Bauer DC.

Diabetes Care. 2012 Jul;35(7):1525-31. doi: 10.2337/dc11-2184.


Postsurgical treatment of early-stage breast cancer with electronic brachytherapy: outcomes and health-related quality of life at 1 year.

Patel RR, Beitsch PD, Nichols TD, Lorenzetti JD, Wurzer JC, Tucker JC, Nunn GW, Laduzinsky SJ, Kugler MA, Simmons DL, Gilligan MS, Roy T, Foley JK, Thropay JP, Odou MW, Bornstein BA, Tito EP, Chadha M, Boolbol SK, Lane SC, White JG.

Am J Clin Oncol. 2013 Oct;36(5):430-5. doi: 10.1097/COC.0b013e31825493bb.


Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: Secondary analysis of the ACCORD clinical trial data.

Bonds DE, Miller ME, Dudl J, Feinglos M, Ismail-Beigi F, Malozowski S, Seaquist E, Simmons DL, Sood A.

BMC Endocr Disord. 2012 May 30;12:5. doi: 10.1186/1472-6823-12-5.


Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy.

Sullivan MD, O'Connor P, Feeney P, Hire D, Simmons DL, Raisch DW, Fine LJ, Narayan KM, Ali MK, Katon WJ.

Diabetes Care. 2012 Aug;35(8):1708-15. doi: 10.2337/dc11-1791. Epub 2012 May 22.


Effect of intensive versus standard blood pressure control on depression and health-related quality of life in type 2 diabetes: the ACCORD trial.

O'Connor PJ, Narayan KM, Anderson R, Feeney P, Fine L, Ali MK, Simmons DL, Hire DG, Sperl-Hillen JM, Katz LA, Margolis KL, Sullivan MD.

Diabetes Care. 2012 Jul;35(7):1479-81. doi: 10.2337/dc11-1868. Epub 2012 May 14.


Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension Study.

Barzilay JI, Davis BR, Pressel SL, Cutler JA, Einhorn PT, Black HR, Cushman WC, Ford CE, Margolis KL, Moloo J, Oparil S, Piller LB, Simmons DL, Sweeney ME, Whelton PK, Wong ND, Wright JT Jr; ALLHAT Collaborative Research Group.

Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):153-62. doi: 10.1161/CIRCOUTCOMES.111.962522. Epub 2012 Mar 6.


Glycaemia and correlates of patient-reported outcomes in ACCORD trial participants.

Ali MK, Feeney P, Hire D, Simmons DL, O'Connor PJ, Ganz-Lord F, Goff D Jr, Zhang P, Anderson RT, Narayan KM, Sullivan MD.

Diabet Med. 2012 Jul;29(7):e67-74. doi: 10.1111/j.1464-5491.2011.03532.x.


Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial.

Anderson RT, Narayan KM, Feeney P, Goff D Jr, Ali MK, Simmons DL, Sperl-Hillen JA, Bigger T, Cuddihy R, O'Conner PJ, Sood A, Zhang P, Sullivan MD; Action to Control Cardiovascular Risk in Diabetes (ACCORD) Investigators.

Diabetes Care. 2011 Apr;34(4):807-12. doi: 10.2337/dc10-1926. Epub 2011 Feb 23.


Expression of cyclooxygenase isoforms in the baculovirus expression system.

Hunter JC, Myres NM, Simmons DL.

Methods Mol Biol. 2010;644:45-54. doi: 10.1007/978-1-59745-364-6_5.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk